openPR Logo
Press release

Clinical Trial Supplies Market Projected to Reach USD 3000 Million by 2026

07-31-2020 05:13 PM CET | Health & Medicine

Press release from: BlueWeave Consulting

Clinical Trial Supplies Market Projected to Reach USD 3000

Global Clinical Trial Supplies Market valued at USD 1867.44 million in 2019, is expected to reach USD 3078.06 million by 2026, at a CAGR of 7.40 % during the projection period. A safe clinical trial needs a healthy supply chain management of the trial drugs, ensuring compliance concerning several local and global practices and the use of available infrastructures. Clinical trial supplies management is necessary for avoiding overproduction, inventory expiration, and oversupply. With the increasing costs of drug development, clinical trial supplies are gaining more significance.

Request to get the report sample pages at : www.blueweaveconsulting.com/clinical-trial-supplies-market-bwc20102/report-sample

Globalization, the increasing number of clinical trials, and several biologics and biosimilar drugs in trials are anticipated to propel the development of this market. Advancements in supply chain management technology are further likely to push the supply market growth. Biopharmaceutical companies increasingly opt for the supply chain management system to reduce cost, increase functional efficiency, and save for R & D's growing burden. They outsource their supply provisions to cut down the costs of supplies and focus more on the trial procedure.

The storage and distribution segment of Clinical Trial Supplies is likely to notice robust growth due to the increasing expansion in outsourced storage and delivery facility. As part of logistics, supply chain management is gaining importance and, in turn, is anticipated to witness growth due to growing pressure to curb R & D costs and technology progression. Cold chain distribution is predicted to record the most accelerated growth due to a mounting number of biologics and temperature-sensitive drugs. However, non-cold chain distribution seems to maintain control over this segment over the prediction period.

Research and development (R & D) is an essential and vital part of medicines and biopharmaceuticals companies. R & D enables them to develop new molecules for various therapeutic applications carrying considerable medical and profitable potential. R&D spending by biopharmaceutical companies has also increased over the years as the companies cannot compromise with R & D efforts. They are increasingly adopting the innovative supply chain management system to improve operational efficiencies and save to invest in R & D cost.

Get more information with toc : www.blueweaveconsulting.com/clinical-trial-supplies-market-bwc20102

North America and Europe are the prime contributors to the global clinical trial supplies market due to the highest number of clinical trials conducted in this region. Many companies with the most progressive technology are engaged in clinical trial supply in the region. The clinical trials in the Asia Pacific entail high costs due to insufficient development. However, it is likely to register high growth due to its varied population, easy access to patients, nearness to North America, and low conversion cost. Latin America and MEA are also anticipated to see significant growth due to an increase in the number of clinical trials initiated in this region.

Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&M Movianto (US), KLIFO A/S (Denmark), and Thermo Fisher Scientific, Inc. (US) and other prominent players.

Contact:

Blueweave consulting
Toll-free: +1-866-658-6826
International: +1-425-320-4776
Email: info@blueweaveconsulting.com
Web: https://www.blueweaveconsulting.com

About Us

BlueWeave Consulting is a one-stop solution for market intelligence regarding various products and services online & offline. We offer worldwide market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solution. BWC has built its reputation from the scratches by delivering quality performance and nourishing the long-lasting relationships with its clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Supplies Market Projected to Reach USD 3000 Million by 2026 here

News-ID: 2101169 • Views:

More Releases from BlueWeave Consulting

Global Organ Preservation Market Size, Share & Growth is Projected to Grow at a …
A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global organ preservation market was worth USD 210.3 million in the year 2020. The data gathered by the study further reveals that the market is estimated to grow at a CAGR of 6.1%, earning revenue of around USD 322.1 million by the end of 2027. The most crucial factors fueling the market growth
Global Animal Wound Care Market Size, Share & Growth is Projected to Grow at a C …
A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global animal wound care market was worth USD 1.1 billion in the year 2020 and is estimated to grow at a CAGR of 5.9%, earning revenue of around USD 1.7 billion by the end of 2027. The growing pet adoption rate, especially in developed countries, is one of the major factors propelling the
Global Dry Transformer Market Size, Share & Growth is Projected to Reach USD 6,9 …
A study recently conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global dry-transformer market was worth USD 4,752.4 million in 2020 and is further projected to reach USD 6,967.6 million by 2027, at a CAGR of 6.2% during the forecast period (2021-2027). Factors driving the market include the burgeoning oil and gas industry, rising need for clean and cost-effective energy, increasing acceptance of dry-transformer
Global PET Foam Market Size, Share and Growth is Projected to Grow at a CAGR of …
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global PET foam market was worth USD 252.5 million in the year 2020. The data gathered by the study reveals that the market is estimated to grow at the CAGR of 11.0%, earning revenue of around USD 504.1 million by the end of 2027. PET Foams or Polyethylene terephthalate foams are thermoplastic closed-cell

All 5 Releases


More Releases for Clinical

Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical